GSTM1 and colorectal carcinoma: Recent meta-analyses confirm that quantitative FIT is highly sensitive for CRC detection [103] and indicated that at a cut-off around 10 μg Hb/g faces has the potential to rule out CRC correctly and decrease colonoscopy rate in 75–80% of symptomatic patients [104].